See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Application · Receptor Biochemistry

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
12415 11-deoxy-11-methylene-15-keto Prostaglandin D2 - >98% 100.780055248619 11-deoxy-11-methylene-15-keto-prostaglandin-d2 11-deoxy-11-methylene-15-keto PGD2 prostaglandins 11-deoxy-11-methylene-15-keto-PGD2 CRTH2 receptors eosinophils stable ligands 100.780055248619
14570 11-deoxy-16,16-dimethyl Prostaglandin E2 53658-98-3 >98% 101.073425414364 11-deoxy-16-16-dimethyl-prostaglandin-e2 11-deoxy-16,16-dimethyl PGE2 11-deoxy-16,16-dimethyl-PGE2 prostaglandins agonists EP2 EP3 receptors 101.073425414364
16783 11-keto Fluprostenol - ≥98% 32.086795580110 11-keto-fluprostenol Fluprostenol Prostaglandin D2 11-keto-fluprostenol analogs DP receptors PGD2 agonists prostaglandins 32.086795580110
18212 13,14-dehydro-15-cyclohexyl Carbaprostacyclin 145375-81-1 >98% 38.551533149171 13-14-dehydro-15-cyclohexyl-carbaprostacyclin PGI2 analogs vasodilation prostaglandins 13,14-dihydro-15-cyclohexyl-carbaprostacyclin 38.551533149171
12610 13,14-dihydro-15-keto Prostaglandin D2 59894-07-4 >98% 79.064287292818 13-14-dihydro-15-keto-prostaglandin-d2 13,14-dihydro-15-keto PGD2 metabolites 13,14-dihydro-15-keto-PGD2 prostaglandins DK PGD2 diketo DKPGD2 CRTH2 DP2 79.064287292818
38612 13(S)-HODE-biotin - ≥98% (may contain trace amounts of free biotin) 17.968545119705 13-s-hode-biotin hydroxy fatty linoleic acids metabolites binding proteins receptors detection 13S-HODE-biotin 13(S)HODE-biotin 13S-HODES 13(S)-HODES 13-HODEs 13(S)HODEs 17.968545119705
20150 14,15-dehydro Leukotriene B4 114616-11-4 >97% 2008-06-02 41.183911602210 14-15-dehydro-leukotriene-b4 14,15-dehydro LTB4 leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition 41.183911602210
12700 15-deoxy-Δ12,14-Prostaglandin D2 85235-11-6 ≥95% 108.501270718232 15-deoxy-12-14-prostaglandin-d2 15-deoxy-Δ12,14-PGD2 PPARs prostaglandins peroxisome proliferator-activated receptors 15-deoxy-DELTA12,14-PGD2 15-deoxy-.DELTA.12,14-PGD2 15-deoxy-d12,14-PGD2 leukemia cells cancer 15d-pgd2 108.501270718232
18570 15-deoxy-Δ12,14-Prostaglandin J2 87893-55-8 ≥95% 87.065636974572 15-deoxy-12-14-prostaglandin-j2 15-deoxy-Δ12,14-PGJ2 PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis 87.065636974572
10010132 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester - ≥98% (isomer mixture) 2008-06-09 19.581055862492 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester 15-deoxy-Δ12,14-PGJ2-2-glycerol ester PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic 19.581055862492
10141 15-deoxy-Δ12,14-Prostaglandin J2-biotin - >98% 2005-10-11 20.766694495600 15-deoxy-12-14-prostaglandin-j2-biotin 15-deoxy-Δ12,14-PGJ2-biotin affinity probes binding proteins cyclopentenones PGs prostaglandins peroxisomes proliferator-activated receptors PPARs anitmitotic antiproliferative genes expressions non-classical non-GPCR gene protein-coupled detected detection interactions biotins ligands complexes nuclear nucleic acids elucidations mechanisms biotinylated PGJ2 biotinamides 20.766694495600
10006692 (+)-15-epi Cloprostenol 54276-22-1 ≥98% 2005-05-18 6.888674033149 -15-epi-cloprostenol (+)-15(S)-Cloprostenol; D-Cloprostenol prostaglandins F2.alpha. PGF2a analogs cloprostenols FP agonists 15(S) 15-epi C-15 epimers receptors 15b 15.beta.-hydroxy enantiomers ligands isomers 6.888674033149
12720 15(R)-15-methyl Prostaglandin D2 Exclusive 210978-26-0 >95% ✓ 56.713848987108 15-r-15-methyl-prostaglandin-d2 15(R)-15-methyl PGD2 15(R)-15-methyl-PGD2 prostaglandins 15-epi-15-methyl-PGD2 15R-15-methyl-PGD2 56.713848987108
16814 15(R)-17-phenyl trinor Prostaglandin F2α 41639-71-8 ≥98% 14.761410464738 15-r-17-phenyl-trinor-prostaglandin-f2 15(R)-17-phenyl trinor PGF2α; 15(R)-Bimatoprost (free acid); 15-epi Bimatoprost (free acid) prostaglandins 15(R)-17-phenyl-trinor-PGF2.alpha. unnatural isomers FP 15(R)-17-phenyl-trinor-PGF2alpha receptors agonists 15-epi-17-phenyl-trinor-PGF2alpha 15-epi-17-phenyl-trinor-PGF2.alpha. 15R-17-phenyl-trinor-PFG2.alpha. 15R-17-phenyl-trinor-PFG2alpha 14.761410464738
10008510 15(R)-Pinane Thromboxane A2 - >98% 2006-06-14 7.662983425415 15-r-pinane-thromboxane-a2 15(R)-PTA2 TXA2 anatagonists TP receptors synthases platelets aggregation analogs inhibits inhibitors inhibition U-46619 cat coronary artery constriction 15-epimer 7.662983425415
10118 15(R)-Prostaglandin D2 - >98% 55.512154696132 15-r-prostaglandin-d2 15(R)-PGD2 PGD2 vasodilation prostaglandins 15(R)-PGD2 15-epi-PGD2 15R-PGD2 DP2 receptors agonists CRTH2 endogenous 15d-pgj2 55.512154696132
12730 15(S)-15-methyl Prostaglandin D2 85280-90-6 >95% 53.872375690607 15-s-15-methyl-prostaglandin-d2 15(S)-15-methyl PG2 15(S)-15-methyl-PGD2 prostaglandins vasoconstriction analogs 15S-15-methyl-PGD2 53.872375690607
16743 15(S)-15-methyl Prostaglandin F2α 35700-23-3 >98% 11.466220994474 15-s-15-methyl-prostaglandin-f2 U-32921; Carboprost; 15(S)-15-methyl PGF2α 15(S)-15-methyl-PGF2alpha 15(S)-15-methyl-PGF2.alpha. analogs 15S-15-methyl-PGF2alpha 15S-15-methyl-PGF2.alpha. 11.466220994474
34722 15(S)-HETE-biotin - ≥98% (may contain trace amounts of free biotin) 12.212928176795 15-s-hete-biotin hydroxy fatty acids binding proteins receptors detection 15S-HETE-biotin 15(S)HETE-biotin 15S-HETES 15(S)-HETES 15(S)HETEs 15-HETEs 15HETEs 12.212928176795
16750 16,16-dimethyl Prostaglandin F2α 39746-23-1 >98% 49.602928176796 16-16-dimethyl-prostaglandin-f2 16,16-dimethyl PGF2α prostaglandins 16,16-dimethyl-PGF2.alpha. 16,16-dimethyl-PGF2alpha analogs FP receptors 49.602928176796
10010839 17-phenoxy trinor Prostaglandin F2α - >98% 2008-02-04 2.405237569060 17-phenoxy-trinor-prostaglandin-f2 17-phenoxy trinor PGF2α PGF2a PGF2.alpha. PGs analogs tetranors FPs receptors luteal IOP glaucoma 2.405237569060
10007931 17-phenyl trinor 8-iso Prostaglandin E2 - ≥95% 2006-07-25 5.631850828729 17-phenyl-trinor-8-iso-prostaglandin-e2 agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 5.631850828729
14810 17-phenyl trinor Prostaglandin E2 38315-43-4 >98% 59.319171270718 17-phenyl-trinor-prostaglandin-e2 17-phenyl trinor PGE2 agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 59.319171270718
16810 17-phenyl trinor Prostaglandin F2α Exclusive 38344-08-0 >98% ✓ 60.571522940187 17-phenyl-trinor-prostaglandin-f2 17-phenyl trinor PGF2α; Bimatoprost (free acid) analogs agonists FP receptors 17-phenyl-trinor-PGF2.alpha. 17-phenyl-trinor-PGF2alpha prostaglandins intraocular pressure iop 60.571522940187
16820 17-phenyl trinor Prostaglandin F2α ethyl amide 155206-00-1 >97% 35.135654410364 17-phenyl-trinor-prostaglandin-f2-ethyl-amide 17-phenyl trinor PGF2α ethyl amide; Bimatoprost; 15(S)-Bimatoprost lumigan prostaglandins N-ethylamides intraocular hypotensive agonists IOP glaucoma 17-phenyl-trinor-pgf2alpha-ethylamide 17-phenyl-trinor-pgf2a-ethylamide 17-phenyl-trinor-pgf2.alpha.-ethylamide FP receptors ophthalmology 35.135654410364
14910 19(R)-hydroxy Prostaglandin E2 64625-54-3 >98% 65.321583793738 19-r-hydroxy-prostaglandin-e2 19(R)-hydroxy PGE2; 19(R)-OH PGE2 19(R)-hydroxy-PGE2 19(R)-OH-PGE2 19R-hydroxy-PGE2 19R-OH-PGE2 metabolites semen agonists EP2 prostaglandins receptors hydroxylated PGs 65.321583793738
20190 20-hydroxy Leukotriene B4 79516-82-8 >97% 64.968305709023 20-hydroxy-leukotriene-b4 20-hydroxy LTB4 leukotrienes metabolites 20-hydroxy-LTB4 20-OH-LTB4 hydroxylated 64.968305709023
20195 20-trifluoro Leukotriene B4 115178-97-7 >97% 175.757513812155 20-trifluoro-leukotriene-b4 20-trifluoro LTB4 20-CF3-LTB4 leukotrienes 20-trifluoro-LTB4 metabolites 175.757513812155
62160 2-Arachidonoyl Glycerol 53847-30-6 >95% (as a 9:1 mixture of the 2-AG and 1-AG) 43.426339384372 2-arachidonoyl-glycerol 2-AG endocannabinoids anandamides 2AG fatty acids CB1 neuroscience neurochemistry endocrinology cannabinoids cbs synthetic 43.426339384372
62165 2-Arachidonyl Glycerol ether 222723-55-9 >98% 32.466556169429 2-arachidonyl-glycerol-ether Noladin; 2-AG ether endocannabinoids 2AG anandamides CB1 receptor selective selectivity agonists stable 2-AG-ether analogs fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic 32.466556169429
9000787 2-chloro-3-Deazaadenosine 40656-71-1 ≥98% 2011-06-29 1.173011049723 2-chloro-3-deazaadenosine 2-CADO; NSC 158900; 6-Amino-2-chloropurine riboside adenosine receptors analogs agonists seizures neuroscience NSC158900 NSC-158900 neurotransmission A1 A2A A2B A3 G protein-coupled 2-chloroadenosine 2CA 2-CA 2 CA CADO 1.173011049723
90055 (±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide 166100-39-6 >95% 20.331703499079 -2-methyl-arachidonoyl-2-fluoroethylamide O-689; 2-Methyl-2'-fluoro Anandamide; 2-methyl-2'-fluoro AEA anandamides ethanolamides AEA cannabinoids receptors CB1 binding affinity faah fatty acid hydrolases .DELTA.9-THC .DELTA.9THC DELTA9-THC DELTA9THC D9-THC D9THC tetrahydrocannabidiol selective analogs neurochemistry neuroscience fluoromethanandamide 20.331703499079
10005707 (2S)-OMPT - ≥98% 2005-10-19 33.258149171270 -2s-ompt GPR lysophosphatidic acids lipids mediators receptors LPA1/Edg-2 LPA2/Edg-4 LPA3/Edg-7 LPA4/GPR23 agonists calcium mobilization Sf9 cells (2R)-OMPT release assays LPA3-transfected rat hepatoma Rh7777 33.258149171270
18211 5-cis Carbaprostacyclin 69609-77-4 >99% 2.117771639042 5-cis-carbaprostacyclin (5Z)-6a-Carbaprostaglandin I2 PGI2 analogs prostaglandins 5(z)-carbaprostacyclin 5z-carbaprostacyclin 5-cis-carbaprostacyclin 2.117771639042
10008585 5-cis Iloprost - ≥97% 2006-07-17 51.315414364641 5-cis-iloprost 5-cis Ciloprost agonists IP receptors vasodilator hypostensive antiduretic hypertension analogs PGI2 prostaglandins carbaprostacyclin selective selectivity C-5 cis-isomers 15-keto-iloprost 51.315414364641
34250 5-OxoETE 106154-18-1 ≥95% 17.745280189423 5-oxoete 5-KETE 5-HETEs oxo-acids 5-LOs metabolites chemotactic fatty 5-lipoxygenases 5-oxo-etes polyunsaturated PUFAs 17.745280189423
100025 5-OxoETE Receptor Polyclonal Antibody - 2004-12-14 255.799907918968 5-oxoete-receptor-polyclonal-antibody TG1019; R527 WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting 255.799907918968
10010109 8-DY547-cGMP - ≥98% 2008-10-23 774.385911602210 8-dy547-cgmp CNGA2 channels activators fluorescences cyclic nucleotides 774.385911602210
10008436 8-iso-17-phenyl trinor Prostaglandin F2β - >98% 2006-06-14 11.866187845303 8-iso-17-phenyl-trinor-prostaglandin-f2 Bimatoprost analogs prostaglandins PGF2alpha PGF2.alpha. PGF2beta PGF2.beta. agonists 17-phenyl-trinor FP receptors inhibits inibitors inhibition isomers ophthalmology glaucoma IOP intraocular pressure ophthalmology 11.866187845303
10012588 A-803467 944261-79-4 ≥98% 2009-02-14 0.165745856354 a-803467 Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R 0.165745856354
13653 ABT-869 796967-16-3 ≥98% 2010-12-09 38.810202578269 abt-869 Linifanib inhibitors RTK tyrosine kinases VEGF PDGF cancers KDR Flt1 Flt3 Flt4 CSF-1R KIT acute myeloid leukemia antiproliferative anti-proliferative ABT 869 ABT869 Indazoles 38.810202578269
10011454 Adenosine Receptor A2A Monoclonal Antibody (Clone 7FG-G5-A2) - 2009-01-09 192.685345303867 adenosine-receptor-a2a-monoclonal-antibody-clone-7fg-g5-a2 ADORA2A; A2AR antibodies antiserum receptors WB western blots blotting immunoblotting 192.685345303867
13626 AFP 07 (free acid) Exclusive 788799-13-3 ≥98% ✓ 2011-08-31 13.792541436464 afp-07-free-acid prostaglandins I2 PGI2 PGs prostacyclins IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 AH-23848 prostanoids platelets vasodialation aggregation pulmonary vascular AH23848 AFP07 AFP-07 13.792541436464
10010129 AG-041R Exclusive 199800-49-2 ≥98% ✓ 2008-12-16 58.820828729281 ag-041r CCKs gastrin receptors antagonist cancers proliferations apoptosis NS-398 NS398 NS 398 58.820828729281
13297 AG-126 118409-62-4 ≥95% 2009-07-14 5.198800315706 ag-126 Tyrphostin AG-126 tyrphostins proteins tyrosine inhibitors inhibits inhibition cells growth epidermal growth factors receptors kinase GFRK EGFs EGFRK PDGF PDGFRK platelet-derived platelet derived phosphorylation ERK1 p44 ERK2 p42 TNF-α TNFα TNF α NF-κB NFκB NF κB COX-2 COX2 iNOS inflammation 5.198800315706
10010592 AG-1296 146535-11-7 >98% 2008-05-09 7.666917127072 ag-1296 Tyrphostin AG-1296 tyrphostins AG1296 PDGFR PTK SCF inhibitors inhibits inhibition receptors kinases proteins platelet-derived platelet derived growth factors in vitro cancer glioma athrosclerosis restenosis AG1296 AG 1296 7.666917127072
10010244 AG-1478 153436-53-4 ≥98% 2008-04-22 10.902276243094 ag-1478 NSC 693255; Tyrphostin AG-1478 NSC 693255 EGFR PTK inhibitors inhibits inhibition kinases receptors cancers antitumor leioyoma myometrium 175178-82-2 AG1478 AG 1478 t4182 10010244-t4182 10.902276243094
10010248 AG-17 10537-47-0 ≥98% 2007-09-18 1.714819379516 ag-17 NSC 242557; Tyrphostin 9; Malonoben; Tyrphostin AG-17; SF 6847; GCP 5126; RG-50872 proteins tyrosine kinases PTK inhibitors inhibits antiproliferative epidermal growth factor EGF receptors proliferations carcinomas AG17 AG 17 SF6847 SF-6847 GCP-5126 GCP5126 1.714819379516
10010300 AG-18 118409-57-7 >98% 2007-12-20 1.702732681683 ag-18 RG-50810; TX 825; Tyrphostin AG-18; Tyrphostin 23; RG-50858 proteins tyrosines kinases PTKs inhibitors inhibition inhibits antiproliferative epidermal growth factors EGF receptors proliferations carcinoma cancers epidermoid cell lines A431 AG18 AG 18 A23 A-23 A23 RG50810 RG 50810 RG50858 RG 50858 TX-825 TX825 1.702732681683
10010315 AG-183 122520-90-5 ≥98% 2007-09-07 1.496800184161 ag-183 Tyrphostin 51 proteins tyrosine kinases PTKs inhibitors inhibition inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas cancers epidermoid AG183 AG 183 1.496800184161
10010314 AG-213 122520-86-9 ≥97% 2008-02-05 2.466539427423 ag-213 Tyrphostin AG-213; Tyrphostin 47 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas A431 epidermal AG213 Ag 213 118409-60-2 2.466539427423
10010568 AG-370 134036-53-6 >95% (cis/trans mixture) 2009-01-09 1.229594843462 ag-370 NSC 651712 PTK inhibitor tyrphostin tyrosine PDGF receptor kinase EGF receptor antiproliferative 1.229594843462
10010311 AG-490 133550-30-8 ≥98% 2007-12-01 7.543591160220 ag-490 PTK tyrosine kinase inhibitors inhibition inhibits antiproliferatives tyrphostins leukemia Jak-2 Jak2 AG490 7.543591160220
10010242 AG-494 133550-35-3 ≥98% 2008-02-08 1.671809392265 ag-494 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative RG-13022 epidermal growth factors EGFs receptrors cancers proliferation 1.671809392265
10010312 AG-82 118409-58-8 ≥95% 2008-03-14 4.373550644567 ag-82 Tyrphostin AG-82; NSC 676484; RG-50875; Tyrphostin 25 proteins tyrosines kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas blockers A431 AG82 AG 82 RG-50875 RG50875 A25 A-25 4.373550644567
10010243 AG-825 149092-50-2 ≥98% 2008-01-24 2.012059984214 ag-825 Tyrphostin AG-825 Her-2 Her-2/neu erbB tyrosine kinases EGF EGFR cancers anti-cancer prostate breast signal transduction inhibitors inhibition inhibits AG825 AG 825 2.012059984214
10793 AG-879 148741-30-4 ≥95% 2011-05-06 2.752812154696 ag-879 Tyrphostin AG-879 PTKs inhibitors tyrphostins tyrosine kinases antiproliferative NGF TrkA ErbB2 FLK-1 AG879 AG 879 inhibited inhibition 2.752812154696
10010313 AG-99 122520-85-8 ≥98% 2007-12-19 1.334737569060 ag-99 Tyrphostin 46 protein tyrosine kinase PTKs inhibitor inhibits inhibition antiproliferatives epidermal growth factors EGFs receptors proliferation carcinoma cancers blochers EGF-dependent A431 cell lines AG99 AG 99 1.334737569060
13203 Agomelatine 138112-76-2 ≥98% 2009-11-06 1.596353591160 agomelatine Valdoxan® melatonin circadian rhythm MT1 MT2 serotonin 5-HT noradrenaline dopamine antidepressant anti-depressant S20098 S-20098 S 20098 1.596353591160
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 76.191248618784 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 76.191248618784
14050 AH 6809 33458-93-4 ≥98% 88.760055248619 ah-6809 EP1 EP2 receptors antagonists AH6809 DP PGE2 prostaglandins ah-6809 88.760055248619
10011546 AL 34662 210580-75-9 ≥98% 2008-11-12 45.421248618784 al-34662 AL 34497 serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine 45.421248618784
16735 AL 8810 246246-19-5 >98% 38.367000789266 al-8810 FP antagonists prostaglandins PGFs receptors AL8810 AL-8810 PGF2alpha PGF2.alpha. analogs 38.367000789266
10113 AL 8810 isopropyl ester 208114-93-6 >98% 52.654996930632 al-8810-isopropyl-ester FP antagonists prostaglandins PGFs receptors AL8810 AL-8810 PGF2alpha PGF2.alpha. analogs esters 52.654996930632
10008370 AL 8810 methyl ester - >98% 2006-10-05 7.634198895027 al-8810-methyl-ester FP antagonists prostaglandins PGFs receptors AL8810 AL-8810 PGF2alpha PGF2.alpha. analogs esters intraocular 7.634198895027
13648 Alfuzosin (hydrochloride) 81403-68-1 ≥98% 2010-07-19 0E-12 alfuzosin-hydrochloride Uroxatral; SL 77499-10 α1-adrenergic receptors antagonists lower urinary tract symptoms benign prostatic hyperplasia BPH adrenoceptors α1A α1B α1D contractions smooth muscles antihypertensives vasodilators urinary flow 133880-44-1 Urion Alfoten SL 77-499-10 anti-hypertensives alpha 1 .alpha.1 Xatral Quinazolines 0E-12
91054 Arachidonoyl 2'-Chloroethylamide 220556-69-4 >96% 26.423195211786 arachidonoyl-2-chloroethylamide 2'-chloro-AEA; ACEA agonists selective CB1 receptors AEA arachidonoyl ethanolamides cannabinoids selectivity hypothermia FAAH fatty acid amide hydrolases neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines 26.423195211786
90054 Arachidonoyl-2'-Fluoroethylamide 166100-37-4 >98% 4.681927886013 arachidonoyl-2-fluoroethylamide 2'-fluoro Anandamide; 2'-fluoro AEA anandamides cannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors neurochemistry neuroscience 4.681927886013
90050 Arachidonoyl Ethanolamide 94421-68-8 ≥98% 44.704675456451 arachidonoyl-ethanolamide Anandamide; AEA cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology 44.704675456451
13498 ARRB2 Polyclonal Antibody - 2009-09-22 42.829944751381 arrb2-polyclonal-antibody β-Arrestin-2 WB IHC western blots blotting immunoblotting antibodies immunohistochemisty ARRB-2 βarrestin2 β-arrestin2 β arrestin 2 β2R receptors adrenergic 42.829944751381
90052 Arvanil 128007-31-8 >98% 13.559889502762 arvanil N-Vanillylarachidonamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides neurochemistry neuroscience 13.559889502762
10626 AS-1269574 Exclusive 330981-72-1 ≥98% ✓ 2011-01-17 7.888581952118 as-1269574 diabetes glucose insulin receptors pancrease b-cells b cells .beta.-cells beta-cells β-cells β GPR119 GPR-119 GPR 119 lysophosphatidylcholine LPC oleoylethanol amides OEA agonist Ethanolamines Aminoethanols 7.888581952118
10008640 Asthma Treatment Standard Set - 2006-07-13 12.548692449355 asthma-treatment-standard-set CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction montelukast pranlukast zafirlukast zileuton 10006967 packs 12.548692449355
10008612 azido-FTY720 - ≥98% 2006-09-13 52.768238182934 azido-fty720 sphingosine 1 phosphate S1P1 S1P3 S1P4 S1P5 immunosuppressant kinases photoreactive agonists analogs allograft transplants inhibits inhibitors inhibition lymphocytes emigration lymphoid organs in vivo Azido FTY720 FTY 720 52.768238182934
10009644 BAY-43-9006 284461-73-0 ≥98% 2011-09-13 25.839792817680 bay-43-9006 Sorafenib; Nexovar® inhibitors raf-1 b-raf receptors tyrosine kinases VEGF VEGFR PDGF PDGFR cancers angiogenesis apoptosis tumors cells cellular proliferation Flt-3 c-KIT carcinoma growth factor tosylate 25.839792817680
10532 BayCysLT2 Exclusive 712313-33-2 ≥95% ✓ 2010-09-22 2.552633517495 baycyslt2 CAY10633 HAMI3379 cysLT2 receptors cardiovascular disease antagonists leukotrienes LTC4 LTD4 cysteinyl HAMI 3379 HAMI-3379 cyslts CAY10633 CAY-10633 CAY 10633 2.552633517495
10156 BAY-u3405 116649-85-5 >98% 2004-11-17 19.377381215470 bay-u3405 Ramatroban human medications allergic rhinitis antagonists thromboxanes TP receptors DP2/CRTH2 prostaglandins PGD2 7-transmembrane GPCRs G-protein-coupled BAYu3405 19.377381215470
70770 BAY-u9773 154978-38-8 >95% 2005-03-30 42.649613259668 bay-u9773 asthma leukotrienes CysLTs allergy antagonists cysteinyls receptors 7-transmembranes pranlukasts montelukasts CysLT2 CysLT1 CysLT-1 CysLT-2 42.649613259668
18230 Beraprost (sodium salt) 88475-69-8 >98% 76.308876611418 beraprost-sodium-salt TRK 100; Procyclin; ML 1129 prostaglandins inhibitors inhibits PGI2 prostacyclin platelets aggregation pulmonary atherosclerosis hypertension analogs salts ML-1129 ML1129 TRK-100 TRK100 Na+ 76.308876611418
11022 BIBF 1120 928326-83-4 ≥95% 2011-11-10 6.088397790055 bibf-1120 Vargatef™ receptors tyrosine kinases inhibitors vascular endothelial growth factor VEGFR platelet-derived growth PDGFR fibroblasts FGFR angiogenesis cancers pulmonary fibrosis diseases 6.088397790055
120112 BLT1 Receptor Blocking Peptide - ~30% 2.192541436464 blt1-receptor-blocking-peptide Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 BLT-1 receptors leukotrienes controls peptides flow cytometry FACS ICC immunocytochemistry antibodies 2.192541436464
120111 BLT1 Receptor Monoclonal Antibody (Clone 7B1) - 27.399629044988 blt1-receptor-monoclonal-antibody-clone-7b1 Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc immunohistochemistry ihc atherosclerosis FC 27.399629044988
120114 BLT1 Receptor Polyclonal Antibody - 6.180524861878 blt1-receptor-polyclonal-antibody Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc atherosclerosis immunoblotting FC 6.180524861878
100019 BLT1 Receptor Polyclonal Antiserum - 2.877071823204 blt1-receptor-polyclonal-antiserum Leukotriene B4 Receptor 1; LTB4 Receptor 1; BLTR1 C-terminus C-terminal intracellular plasma membranes whole cells LTB4R1 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera flow cytometry immunocytochemistry icc WB western blots blotting immunohistochemistry ihc chronic pancreatitis pancreatic cancers pancreas atherosclerosis immunoblotting FC 2.877071823204
320124 BLT2 Receptor Blocking Peptide - 6.357834254143 blt2-receptor-blocking-peptide Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2 peptides controls receptors leukotrienes immunofluorescence flow cytometry FACs WB western blotting blots antibodies 6.357834254143
120124 BLT2 Receptor Polyclonal Antibody - 122.215911602209 blt2-receptor-polyclonal-antibody Leukotriene B4 Receptor 2; LTB4 Receptor 2; BLTR2 LTB4R2 LTB4-R2 receptors antiserum antibodies leukotrienes neutrophils inflammation antisera western blots blotting WB atherosclerosis immunoblotting 122.215911602209
10155 BM 567 284464-77-3 >98% 2005-03-31 43.370676795580 bm-567 platelets thromboxanes TXA2 atherosclerosis synthases inhibits inhibition inhibitors antagonists BM567 BM-567 thrombogenic vasocontrictors TP receptors eicosanoids strokes myocardial infarctions GPCR vascular smooth muscles protein-coupled license:liege 43.370676795580
10488 Bupropion (hydrochloride) 31677-93-7 ≥98% 2010-08-16 6.125262942501 bupropion-hydrochloride NSC 315851 34841-36-6 Zyban Wellbatrin inhibitors inhibits inhibition reuptake dopamine norepinephrine Voxra Aplenzin Amfebutamone antagonists neuronal acetylcholine nicotinic receptors nAChR antidepressant depression neurosciences Wellbutrin 1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone GlaxoSmithKline Brand 2 of Bupropion Hydrochloride GlaxoSmithKline Brand 1 of Bupropion Hydrochloride Glaxo Wellcome Brand 3 of Bupropion Hydrochloride Glaxo Wellcome Brand 2 of Bupropion Hydrochloride Glaxo Wellcome Brand 1 of Bupropion Hydrochloride Esteve Brand of Bupropion Hydrochloride Bupropion Hydrochloride Bupropion Hydrochloride Zyban (Anti-Smoking) Amfebutamone Wellbutrin Bupropion Bupropion Zyntabac Quomen Isomer 6.125262942501
13740 Butaprost Exclusive 69685-22-9 >98% ✓ 93.793453038673 butaprost TR 4979; 15-deoxy-16S-hydroxy-17-cyclobutyl PGE1 methyl ester PGE2 prostaglandins R-butaprost PGE1 methyl esters EP2 receptors (R)-butaprost (R)butaprost 93.793453038673
12050 BW 245C 72814-32-5 >98% 82.170593922651 bw-245c PGD2 hydantoins agonists BW245C prostaglandins BW-245C 82.170593922651
70090 BW 723C86 160521-72-2 >98% 22.216353591159 bw-723c86 bw-723c86 bw723-c86 5-ht2b agonist anxiolytic serotonin 5-hydroxy-tryptamine 5-OH-tryptamine bw723c86 receptors selective endocrinology neurochemistry neuroscience 22.216353591159
12060 BW A868C 118675-50-6 >98% 82.880662983425 bw-a868c hydantoin DP receptors antagonists BW245C adenylate cyclase antiaggregatory BWA868C BW-A868C BW-245C prostaglandins PGD2 DP1 82.880662983425
92350 Capsaicin 404-86-4 ≥95% 2004-04-01 11.165374901341 capsaicin Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers 11.165374901341
10007518 Capsazepine 138977-28-3 ≥98% 2006-03-29 58.537209944750 capsazepine vanilloid receptors 1 VR1 transient potential TRP endogenous stimuli tissues injury inflammation pain antagonists capsaicin Ca2+ neonatal rats dorsal root ganglias Chinese hamsters ovary ovaries cells 58.537209944750
18210 Carbaprostacyclin 69552-46-1 >99% 82.885651144435 carbaprostacyclin Carbacyclin; cPGI analogs vasodilation PPARs peroxisome proliferator-activated receptors PGI2 prostaglandins atherosclerosis cPGI Carbacyclin 82.885651144435
19010 Carbocyclic Thromboxane A2 74034-56-3 >98% 7.788453038674 carbocyclic-thromboxane-a2 CTA2; Carbocyclic TXA2 thromboxanes analogs TXA2 vasoconstriction CTA2 atherosclerosis 7.788453038674
13702 Cav1.2 Calcium Channel Monoclonal Antibody (Clone S57-46) - 2009-11-05 1.281767955801 cav1-2-calcium-channel-monoclonal-antibody-clone-s57-46 antibodies western blotting blots immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC channels ions fusion proteins gated voltage-gated ligand-gated voltage ligand 1.281767955801
13703 Cav1.3 Calcium Channel Monoclonal Antibody (Clone S38-8) - 2009-11-05 1.281767955801 cav1-3-calcium-channel-monoclonal-antibody-clone-s38-8 antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand 1.281767955801
13706 Cav1.3 Calcium Channel Monoclonal Antibody (Clone S48A-9) - 2009-11-12 1.281767955801 cav1-3-calcium-channel-monoclonal-antibody-clone-s48a-9 antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand 1.281767955801
13700 Cavβ1 Calcium Channel Monoclonal Antibody (Clone S7-18) - 2009-10-24 1.281767955801 cav-1-calcium-channel-monoclonal-antibody-clone-s7-18 antibodies western blotting immunoblotting WB IHC ICC IF immunohistochemistry immunocytochemistry immunofluorescence perox ions channels membrane proteins voltage ligands gated 1.281767955801
13701 Cavβ4 Calcium Channel Monoclonal Antibody (Clone S10-7) - 2009-11-05 1.281767955801 cav-4-calcium-channel-monoclonal-antibody-clone-s10-7 western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels antibodies epilepsy IGE JME subunits gated voltage-gated ligand-gated ligand voltage 1.281767955801
13747 CAY10408 212310-16-2 >98% 30.079502762430 cay10408 PGE2 prostaglandins R-butaprost C-16 epimer EP2 receptors (R)-butaprost (R)butaprost PGE2 30.079502762430
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 95.979825046041 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 95.979825046041
10005033 CAY10444 Exclusive 298186-80-8 ≥98% ✓ 2004-10-05 58.748941068140 cay10444 BML-241 receptors antagonists S1P3 EDG3 sphingosines sphingosine-1 sphingosine1 phosphates Hela cells G-proteins CAY-10444 BML241 58.748941068140
10005633 CAY10448 - ≥98% 2004-10-01 17.571325966850 cay10448 capsaicin capsicum vanilloids receptors antagonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs transient potential VR1 pain TRPV1 neurochemistry neuroscience 17.571325966850
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 64.277476979742 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 64.277476979742
10005072 CAY10455 290374-09-3 >98% 2004-11-09 8.140732044199 cay10455 SKM 4-45-1 anandamides AEAs neurons fatty acid amide hydrolase FAAH analogs arachidonyl ethanolamides transporters acyl fluorescent fluorescence substrates cellular trafficking neurochemistry neuroscience 8.140732044199
10006735 CAY10471 627865-18-3 ≥98% 2005-06-22 17.541892265193 cay10471 ramatroban DP2 CRTH2 antagonists TP receptors prostaglandins PGD2 7-transmembranes GPCRs G protein-coupled BAY-u3405 human medications allergic rhinitis analogs 17.541892265193
10007955 CAY10498 863202-33-9 ≥98% 2006-08-02 41.749779005525 cay10498 2-phenyl-amino-N6-endo-norbornyladenine adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology 41.749779005525
10008669 CAY10508 878533-35-8 ≥98% 2006-08-04 35.284060773480 cay10508 1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic 35.284060773480
10009167 CAY10509 1245699-47-1 ≥98% 2006-10-25 87.593895027624 cay10509 FP PGF2.alpha. glaucoma compound A receptors agonists intraocular pressure glaucoma IOP ophthalmology 87.593895027624
10009168 CAY10510 291303-34-9 ≥98% 2006-10-25 87.448038674032 cay10510 FP PGF2.alpha. glaucoma Compound B receptors agonists intraocular pressure glaucoma IOP ophthalmology 87.448038674032
10010396 CAY10535 Exclusive - >98% ✓ 2008-05-06 198.923480662983 cay10535 TPbeta TPb TP.beta. TPalpha TP.alpha. TPa TXA2 thromboxanes antagonists platelet aggregations U-46619 U46619 198.923480662983
16835 CAY10580 Exclusive 64054-40-6 ≥96% ✓ 2009-03-16 77.803241252302 cay10580 PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis 77.803241252302
10012424 CAY10583 Exclusive 862891-27-8 ≥98% ✓ 2009-07-21 61.190257826887 cay10583 LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation 61.190257826887
13143 CAY10587 Exclusive 1082058-99-8 ≥98% ✓ 2009-07-02 14.766325966851 cay10587 free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors 14.766325966851
10012553 CAY10595 Exclusive 916047-16-0 ≥97% ✓ 2009-07-08 8.011823204419 cay10595 DP2 PGD2 CRTH2 chemotaxis inflammation antagonists prostaglandins PGDs 8.011823204419
10012539 CAY10597 916046-55-4 ≥98% 2009-03-11 3.705348066298 cay10597 DP2 PGD2 CRTH2 chemotaxis inflammation antagonist 5-chloro-1'-[(2-fluorophenyl)methyl]-2,2',5'-trioxo-spiro[3H-indole-3,3'-pyrrolidine-1(2H)-acetic acid 3.705348066298
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 55.690121546961 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 55.690121546961
13358 CAY10608 Exclusive 457897-92-6 ≥98% ✓ 2010-04-29 1.305248618784 cay10608 N-Methyl-D-aspartate NMDA receptors antagonists glutamate glycine propanolamine NR2B subunit AMPA kainate neuroprotection neurochemistry antagonizes potently selectively non-competitively 1.305248618784
13615 CAY10614 Exclusive 1202208-36-3 ≥98% ✓ 2010-03-22 11.377624309392 cay10614 1115270-65-9 Lipids A endotoxins lipopolysaccharides LPS gram-negative bacterias infections toll-like receptor 4 TLR4 immune responses antagonists sepsis inflammation 11.377624309392
10820 CAY10651 Exclusive - ≥98% ✓ 2011-06-15 0E-12 cay10651 Glutamate neurotransmitters receptors mGlu5 pain anxiety antagonists gastresophageal reflux diseases dyskinesia fragile X syndromes drug addictions cortical astrocytes functional binding assays mobilization calcium CNS 0E-12
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 38.500490737732 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 38.500490737732
10006590 CB1 Receptor (C-Term) Polyclonal Antibody - 2005-05-10 74.772228360957 cb1-receptor-c-term-polyclonal-antibody Cannabinoid Receptor 1 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB IHC immunohistochemistry neuroscience neurochemistry endocrinology immunoblotting cannabinoids cbs synthetic 74.772228360957
101500 CB1 Receptor Polyclonal Antibody - 37.924069981583 cb1-receptor-polyclonal-antibody Cannabinoid Receptor 1 Polyclonal Antibody cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB neuroscience neurochemistry endocrinology immunoblotting 37.924069981583
101550 CB2 Receptor Polyclonal Antibody - 54.599819186338 cb2-receptor-polyclonal-antibody Cannabinoid Receptor 2 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry endocrinology immunoblotting IHC immunohistochemistry 54.599819186338
10010712 CB2 Receptor Polyclonal FITC Antibody - 2008-01-15 39.452872928177 cb2-receptor-polyclonal-fitc-antibody Cannabinoid Receptor 2 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry GPCRs FC flow cytometry immunoblotting IF immunofluorescence 39.452872928177
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 63.879109883364 chemokine-like-receptor-1-polyclonal-antibody GPCR ChemR23; Resolvin E1 Receptor; ChemerinR; DEZ; CMKLR1; ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 63.879109883364
10009524 ChREBP DBD (human recombinant) - >85% by SDS-PAGE 2007-04-12 1.953729281768 chrebp-dbd-human-recombinant GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams-Beuren Syndrome Chromosome Region 14 EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology CAS number # 352845-69-3 1.953729281768
16831 Cicaprost Exclusive 94079-80-8 ≥98% ✓ 2010-09-16 48.114404821697 cicaprost ZK 96480 Prostaglandin I2 PGI2 prostacyclins vasodilators cardiovascular diseases inflammation mitogenesis cancers orally active inflammatory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)-Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 48.114404821697
18216 Ciprostene (calcium salt) 81703-55-1 ≥98% 38.628701657458 ciprostene-calcium-salt U-61431F; Ciprostene calcium PGI2 analogs vasodilation 9.beta.-methyl 9beta-methyl carbaprostacyclin prostaglandins salts cat U61431F atherosclerosis 38.628701657458
10011126 Clobenpropit (hydrobromide) 145231-35-2 ≥98% 2008-12-04 0.882665745856 clobenpropit-hydrobromide Carbamimidothioic Acid; VUF-9153 histamines receptors antagonist GABA neurons brains seizures 0.882665745856
13657 (±)-Clopidogrel (hydrochloride) 90055-48-4 ≥98% 2011-04-11 4.077348066299 -clopidogrel-hydrochloride platelets aggregation antagonists P2Y12 receptors ADPs prodrugs anti-thrombic antithrombic 4.077348066299
16765 (+)-Cloprostenol 54276-21-0 ≥97% 61.374996053669 -cloprostenol (+)-16-m-chlorophenoxy tetranor Prostaglandin F2α; D-Cloprostenol; (+)-16-m-chlorophenoxy tetranor PGF2α PGF2.alpha. PGF2alpha luteolysis analogs prostaglandins agonists FP receptors enantiomer pharma:6 61.374996053669
16766 (+)-Cloprostenol (sodium salt) 62561-03-9 ≥98% 60.455106550907 -cloprostenol-sodium-salt (+)-16-m-chlorophenoxy tetranor Prostaglandin F2α; (+)-16-m-chlorophenoxy tetranor PGF2α; D-Cloprostenol FP receptors agonists luteolysis analogs PGF2.alpha. PGF2alpha prostaglandins salts Na+ D-Cloprostenol pharma:4 60.455106550907
16764 Cloprostenol (sodium salt) 55028-72-3 ≥98% 65.293245856353 cloprostenol-sodium-salt DL-Cloprostenol; (±)-16-m-chlorophenoxy tetranor Prostaglandin F2α; (±)-16-m-chlorophenoxy tetranor PGF2α PGF2.alpha. PGF2alpha luteolysis analogs prostaglandins agonists FP receptors (+/-)-cloprostenol ±cloprostenol DL-Cloprostenol pharma:3 65.293245856353
120500 CysLT1 Receptor Polyclonal Antibody - 71.259303867403 cyslt1-receptor-polyclonal-antibody Cysteinyl Leukotriene Receptor 1 cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT1 human flow cytometry asthma peptido-leukotrienes FACS antisera immunochemistry icc immunohistory ihc antiserum wb western blotting blots atherosclerosis immunoblotting immunocytochemistry immunohistochemistry FC 71.259303867403
120550 CysLT2 Receptor (C-Term) Polyclonal Antibody - 4.465534069981 cyslt2-receptor-c-term-polyclonal-antibody Cysteinyl-Leukotriene Receptor 2 cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT2 human flow cytometry asthma peptido-leukotrienes wb western blots blotting leukotrienes CysLTs cys-LTs antisera antiserum immunohistochemistry ihc atherosclerosis FC immunoblotting 4.465534069981
120560 CysLT2 Receptor (N-Term) Polyclonal Antibody - 6.745690607735 cyslt2-receptor-n-term-polyclonal-antibody Cysteinyl-Leukotriene Receptor 2 cysteinyl-leukotrienes receptors antibodies LTC4 LTD4 LTE4 Cys-LT2 human flow cytometry asthma peptido-leukotrienes western blots blotting antisera antiserum nt wb icc immuncytochemistry ihc atherosclerosis immunohistochemistry facs flow cytometry immunoblotting FC 6.745690607735
160755 DcR2 Polyclonal Antibody - 0E-12 dcr2-polyclonal-antibody TRUNDD; TRAIL-R4 apoptosis cell death TNF DR4 DR5 DcR1 TRID TRAIL antibodies western blots blotting WB antisera antiserum immunoblotting 0E-12
10006876 Diethylstilbestrol 56-53-1 ≥98% 2005-10-03 5.535723756905 diethylstilbestrol synthetics receptors agonists pregnant pregnancies linked breasts cancers congenital abnormalities abnormality offspring 3H-estradiols binding affinities affinity sexes hormones globulins SHBG estrogens 5.535723756905
92355 Dihydrocapsaicin 19408-84-5 ≥98% 7.067521704814 dihydrocapsaicin capsicum peppers VR1 receptors non-myelinated polymodal C-type nociceptive nerve fibers calcium ion channels pain pathways CA2+ vanilloid heat-activated neurochemistry hot extracts burning neuroscience lipid-souble desensitization patyways 7.067521704814
101640 DP1 Receptor Polyclonal Antibody - 2004-10-22 22.917776243093 dp1-receptor-polyclonal-antibody Prostaglandin D2 Receptor 1; PGD2 Receptor 1 isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting 22.917776243093
101740 EP1 Receptor Polyclonal Antibody - 33.782160220994 ep1-receptor-polyclonal-antibody Prostaglandin E2 Receptor 1; PGE2 Receptor 1 PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb icc immunocytochemistry neurochemistry immunoblotting 33.782160220994
101750 EP2 Receptor Polyclonal Antibody - 74.137332998492 ep2-receptor-polyclonal-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 PGE2 prostaglandins antibodies receptors antisera antiserum western blots blotting wb immunofluorescence facs flow cytometry immunoblotting icc immunocytochemistry 74.137332998492
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 30.416372007366 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 30.416372007366
600340 EP2 Receptor (rat) STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-09-20 33.266108041743 ep2-receptor-rat-step-reporter-assay-kit-luminescence Prostaglandin E2 Receptor 2; PGE2 Receptor 2 prostaglandins E2 PGE2 prostanoids G protein-coupled receptors GPCRs EP1 EP3 EP4 signal transduction tissues regulation cells mediates cAMP cyclic messenger pathways mucosal protection gastrointestinal secretions motility immunity inflammation mice mouse murine tumors cancers cancer-associated immunodeficiency dendritic-cell differentiation in vitro neuroprotective NMDA toxicity oxygen glucose deprivation agonists antagonists therapeutics Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening 33.266108041743
101760 EP3 Receptor Polyclonal Antibody - 31.885082872927 ep3-receptor-polyclonal-antibody Prostaglandin E2 Receptor 3; PGE2 Receptor 3 PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb C-terminus WB ICC immunocytochemistry neurochemistry immunoblotting 31.885082872927
101775 EP4 Receptor (C-Term) Polyclonal Antibody - 34.855861376192 ep4-receptor-c-term-polyclonal-antibody Prostaglandin E2 Receptor 4; PGE2 Receptor 4 PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb immunocytochemistry ICC C-terminus IHC immunohistochemistry immunoblotting 34.855861376192
10479 EP4 Receptor (C-Term) Polyclonal PE Antibody - 2010-11-01 22.719799723756 ep4-receptor-c-term-polyclonal-pe-antibody Prostaglandin E2 Receptor 4 PGE2 receptors antibody antisera antibodies flow cytometry immunocytochemistry FC IF FACS immunoblotting 4 22.719799723756
101770 EP4 Receptor (N-Term) Polyclonal Antiserum - 23.864357734806 ep4-receptor-n-term-polyclonal-antiserum Prostaglandin E2 Receptor 4; PGE2 Receptor 4 PGE2 receptors antibody antisera antibodies nt flow cytometry immunocytochemistry icc FACS WB western blots blotting immunoblotting 23.864357734806
600410 EP4 Receptor (rat) STEP Plate Assay Kit (cAMP method) - 2011-06-28 6.434866482504 ep4-receptor-rat-step-plate-assay-kit-camp-method cell-based assays cells CBAs kits measures measurements prostaglandins E2 PGE2 prostanoids G protein-coupled receptors proteins GPCRs EP1 EP2 EP3 signals transductions mechanisms tissues localizations regulation expression intestines lungs kidneys thymus uterus brains cyclics AMP adenosines monophosphates pathways phosphatidylinositols 3-kinases G1 smooth muscles relaxation gastric secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation human colon cancers colorectal carcinogenesis in vivo neuroprotective excitotoxic injury injuries agonists antagonists therapeutics diseases surface transfections and expression protocols transient technology technologies University of Michigan UM U of M Originus, Inc. USPT United States patents 6897067 6902933 7056741 DNA deoxyribonucleic recombinant proteins cells receptor-mediated endocytosis solution-phase efficiency multiple plasmids constructs intracellular 6.434866482504
600350 EP4 Receptor (rat) STEP Reporter Assay Kit (Luminescence) - 2010-11-04 27.996518460054 ep4-receptor-rat-step-reporter-assay-kit-luminescence PGE2 Receptor 4; Prostaglandin E2 Receptor 4 prostaglandins E2 PGE2 prostanoids G protein-coupled receptors GPCRs EP1 EP2 EP3 signal transduction tissues regulation cells intestines lungs kidneys thymus brains uterus mediates cAMP cyclic messenger pathways PtdIns phosphatidylinositols 3-kinases Gi mediates relaxation smooth muscles gastric acid secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation mice mouse murine colon tumors cancers cancer-associated carcinogenesis in vivo neuroprotective NMDA neuroprotective excitotoxic brain injury agonists antagonists therapeutics Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening 27.996518460054
10010238 Erbstatin Analog 63177-57-1 ≥98% 2008-06-06 0.437569060774 erbstatin-analog Methyl 2,5-dihydoxycinnamate analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers 0.437569060774
10483 Erlotinib 183321-74-6 ≥98% 2010-08-11 27.513535911602 erlotinib Tarceva™; CP 358,774; NSC 718781 tyrosine kinase inhibitor inhibits inhibiting epidermal growth factor receptors EGFR cancers tumor cyclin-dependent cyclin dependent kinase 2 CDK-2 CDK 2 CDK2 JAK-2 JAK2 JAK JAK2V617F CP-358,774 CP-358774 CP 358774 CP358774 CP358,774 NSC-718781 NSC718781 OSI-744 OSI744 R-1415 R1415 R 1415 OSI 744 Quinazolines 27.513535911602
16768 Fluprostenol Exclusive 54276-17-4 ≥95% ✓ 77.438950276243 fluprostenol 16-m-trifluoromethylphenoxy tetranor PGF2α 16767 PGF2alpha PGF2.alpha. analogs FP agonists luteolysis prostaglandins receptors (+)-Fluprostenol 77.438950276243
16769 Fluprostenol isopropyl ester 157283-68-6 ≥98% 41.083650401512 fluprostenol-isopropyl-ester Flu-Ipr; Travoprost; 16-m-trifluoromethylphenoxy tetranor PGF2α isopropyl ester esters prodrug FP receptors agonists intraocular hypotensive IOP glaucoma analogs prostaglandins travatan ophthalmology 41.083650401512
101802 FP Receptor Polyclonal Antibody - 22.597009668508 fp-receptor-polyclonal-antibody Prostaglandin F2α Receptor; PGF2α Receptor prostaglandins PGF2.alpha. WB western blots G-protein-coupled PGF2alpha blotting FPa FPb antibodies antisera antiserum immunoblotting 22.597009668508
10006292 FTY720 162359-56-0 ≥98% 2005-02-09 227.489226519337 fty720 immune modulators sphingosine-1-phosphate receptors ISP1 S1P1 S1P5 S1P3 S1P4 ISP-1 myriocin kinases Abcc1 derivatives Iscaria sinclarii transplants transporter activity FTY 720 227.489226519337
13254 FTY720 phenoxy-biotin Exclusive - ≥95% ✓ 2009-10-28 71.479212707182 fty720-phenoxy-biotin sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 biotins biotinylated biotinamide 71.479212707182
10008933 G-1 881639-98-1 ≥98% 2006-08-30 59.755353591160 g-1 GPR30 estrogen receptors ER ER.alpha. ER ER.beta. 17b-estradiol 17.beta.-estradiol 17beta-estradiol protein-coupled ERalpha ERbeta endoplasmic reticulum signaling agonists in vivo endocrinology 59.755353591160
10600 GABAA Receptor δ-subunit (N-Term) Polyclonal Antibody - 2009-10-22 9.396255371393 gabaa-receptor-subunit-n-term-polyclonal-antibody γ-Aminobutyric Acid A Receptor gamma inhibits inhibitors neurotransmitters WB western blots blotting IP IHC immunoprecipitation immunohistochemistry 9.396255371393
10008346 Gabapentin 60142-96-3 ≥98% 2006-04-20 3.915138121546 gabapentin Neurontin® antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry 3.915138121546
13166 Gefitinib 184475-35-2 ≥98% 2010-02-11 21.037874382088 gefitinib Iressa™; ZD1839 EGFR-TK EGFRs TKs epidermal growth factors inhibitors cancers signal transduction tyrosine kinases inhibits inhibited NSCLC Quinazolinones 21.037874382088
10602 GluR1 (Phospho-Ser831) Polyclonal Antibody - 2009-10-22 0.193370165745 glur1-phospho-ser831-polyclonal-antibody Glutamate Receptor Subunit 1 gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors NMDAR AMPAR kinase immunoblotting 0.193370165745
10601 GluR1 (Phospho-Ser845) Polyclonal Antibody - 2009-10-22 0.193370165745 glur1-phospho-ser845-polyclonal-antibody Glutamate Receptor Subunit 1 gamma inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors NMDA AMPA kinases IHC immunohistochemistry 0.193370165745
10009399 Glycine Receptor Polyclonal Antibody - 2006-12-18 2.080801104972 glycine-receptor-polyclonal-antibody GLY inhibits inhibitors inhibition inhibitory transmitter brainstem spinal cord ligand-gated ion channels family LGICs chemical neurotransmission chloride conductance membranes hyperpolarization synapses cytoplasmic proteins gephyrin alcohol synaptic clustering NMDAR subunit antibodies antisera antiserum WB western blots blotting proteins diseases immunoblotting IHC immunohistochemistry 2.080801104972
10136 GPR17 (C-Term) Polyclonal Antibody - 2010-01-19 18.031282995703 gpr17-c-term-polyclonal-antibody G Protein-Coupled Receptor 17 proteins receptors antibodies western blots WB ICC signals signaling nucleotides CysLTs amino acids blotting immunoblotting FC flow cytometry immunocytochemistry cysteinyl leukotrienes 18.031282995703
10007660 GPR35 Polyclonal Antibody - 2007-04-26 2.405027624309 gpr35-polyclonal-antibody GPCR35; G Protein-Coupled Receptor 35 proteins antibodies western blots WB IHC immunohistochemistry receptors GPR kynureic acid tryptophan hydroxylase blotting immunoblotting 2.405027624309
10007205 GPR40 Polyclonal Antibody - 2007-04-04 8.616169429097 gpr40-polyclonal-antibody Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40 immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC 8.616169429097
10224 GPR55 Polyclonal Antibody - 2010-01-19 42.302316495658 gpr55-polyclonal-antibody G Protein-Coupled Receptor 55 proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic 42.302316495658
10851 Guanabenz (hydrochloride) - ≥98% 2011-09-30 0E-12 guanabenz-hydrochloride Wytensin adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl 0E-12
10009162 GW 627368X Exclusive 439288-66-1 ≥96% ✓ 2007-05-14 32.455359116022 gw-627368x EP4 receptor antagonist TP prostanoid prostaglandin platelets U-46619 aggregation PGE2 EP1 EP2 EP3 GW627368X GW-627368X 32.455359116022
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 34.145428176795 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 34.145428176795
10010410 GW 848687X 612831-24-0 ≥98% 2009-11-25 16.795624309392 gw-848687x Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X 16.795624309392
10008907 GW 9508 885101-89-3 ≥98% 2007-05-14 22.284447513812 gw-9508 agonists GPR40 GPR120 G protein receptors fatty acid glucose insulin MIN6 coupled endocrinology GW9508 22.284447513812
10580 HAMI3379 Exclusive 712313-35-4 ≥90% ✓ 2011-03-14 89.886527229676 hami3379 cysLT2 receptors cardiovascular diseases antagonists leukotrienes LTC4 LTD4 cysteinyl LTs CysLTs perfusion pressure decrease contractility cyclohexanecarboxylic acids 89.886527229676
13705 HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28) - 2009-12-01 0E-12 hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 0E-12
13707 HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37) - 2009-12-01 0E-12 hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP 0E-12
13708 HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28) - 2009-12-01 0E-12 hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 0E-12
13709 HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10) - 2009-12-02 0E-12 hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates 0E-12
10011038 Hemopressin - 2009-08-13 29.761006314127 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic 29.761006314127
19600 I-BOP Exclusive 128719-90-4 ≥95% ✓ 78.543204419889 i-bop IBOP TXA2 analogs vasoconstriction agonists TP receptors 78.543204419889
10137 Icilin 36945-98-9 ≥98% 2004-04-27 13.087421731123 icilin AG 3-5 cooling agent cold receptors CMR1 neurons transient receptors potential VR1 vanilloid receptos TRPM8 neurochemistry neuroscience 13.087421731123
18215 Iloprost 78919-13-8 ≥97% 174.348213627993 iloprost Ciloprost agonists IP receptors vasodilator hypostensive atherosclerosis antiduretic hypertension analogs PGI2 prostaglandins prostacyclin selective selectivity pharma:21 174.348213627993
13139 Imatinib (mesylate) 220127-57-1 ≥98% 2009-04-21 41.939928966061 imatinib-mesylate CGP57148B; Glivec; Gleevec; STI-571 inhibitors tyrosine kinase cancer chronic myelogenous leukemia CML c-ABL kits c-kit platelet-derived growth factor receptors imatinib mesilate 152459-95-5 75-75-2 gleevec 41.939928966061
70275 IMMA - ≥98% 12.406973603437 imma Indomethacin Morpholinylamide; BML-190 cannabinoids receptors CB2 neuroscience neurochemistry endocrinology 12.406973603437
10004974 Ionomycin 56092-81-0 ≥98% 2011-09-30 18.423959484346 ionomycin ionophores calcium transport streptomyces conglobatus intracellular cytokines membranes stores biological SQ23377 SQ-23377 SQ 23377 D10.251.355.391 18.423959484346
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 25.489591774094 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 25.489591774094
160070 IP Receptor (mouse) Polyclonal Antibody - 2004-05-25 19.648040515653 ip-receptor-mouse-polyclonal-antibody PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting 19.648040515653
19021 I-SAP 133538-58-6 ≥98% 7.417679558011 i-sap Iodophenyl sulfonyl amino pinane Thromboxane A2; Iodophenyl sulfonyl amino pinane TXA2 thromboxanes ISAP pinane analogs agtagonists TP receptors atherosclerosis 7.417679558011
10012699 JMV3002 Exclusive 925239-03-8 ≥98% ✓ 2009-03-11 127.926906077347 jmv3002 ghrelins obesity growth hormones foods intake receptors antagonists secretagouge hexarelin-stimulated secretion 127.926906077347
10008131 JNJ-10198409 627512-69-0 ≥98% 2006-10-18 16.361977900553 jnj-10198409 PDGF-BB tyrosine kinases inhibits inhibition inhibitors growth factors receptors platelet-derived antiangiogenic antiproliferative coronary artery smooth muscle cells antagonists ATP binding hydrolysis tumors angiogenesis 16.361977900553
10011925 JNJ-7777120 459168-41-3 ≥98% 2011-02-24 0.482320441989 jnj-7777120 histamines H4 receptors antagonists inflammation Piperazines 0.482320441989
10009458 JTE-013 383150-41-2 ≥98% 2007-01-18 70.191724984653 jte-013 reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers 70.191724984653
13711 KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10) - 2009-12-02 0E-12 kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate 0E-12
13712 KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A-23) - 2009-12-02 0E-12 kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated 0E-12
13713 KCNQ4 Potassium Channel Monoclonal Antibody (Clone S43-6) - 2009-12-02 0E-12 kcnq4-potassium-channel-monoclonal-antibody-clone-s43-6 antibodies western blots blotting immunoblotting immunoprecipitation immunocytochemistry ICC IP KCNQ-4 proteins retigabine hyperpolarization-activated hyperpolarization activated activity activate cation antioconvuslants anti-convulsantd 0E-12
10012659 Ki16425 355025-24-0 ≥95% 2008-11-06 118.064818907305 ki16425 LPA1 LPA2 LPA3 LPA4 LPA5 lysophosphatidic acids cancers antagonist receptors selective 118.064818907305
10505 Kinase Screening Library (96-Well) - 2010-08-09 15.102751381215 kinase-screening-library-96-well screening kinases inhibitors 15.102751381215
13714 Kir2.1 Potassium Channel Monoclonal Antibody (Clone S21-32) - 2009-12-02 0E-12 kir2-1-potassium-channel-monoclonal-antibody-clone-s21-32 channels antibodies western blots blotting immunoblotting WB immunohistochemistry IHC KCNJ2 genes Andersen-Tawil syndromes Andersen Tawil AT defects 0E-12
13715 Kir2.2 Potassium Channel Monoclonal Antibody (Clone S24-1) - 2009-12-02 0E-12 kir2-2-potassium-channel-monoclonal-antibody-clone-s24-1 channels ions antibodies western blots blotting immunoblotting WB immunohistochemistry IHC syndromes Smith-Magenis Smith Magenis chromosomes 17 seventeen tissues genes 0E-12
13716 Kir2.3 Potassium Channel Monoclonal Antibody (Clone S25-35) - 2009-12-04 0E-12 kir2-3-potassium-channel-monoclonal-antibody-clone-s25-35 antibodies channels ions western blots blotting immunoblotting WB IHC immunohistochemistry genes proteins potassiums 0E-12
13717 Kv3.1b Potassium Channel Monoclonal Antibody (Clone S16B-8) - 2009-12-04 0E-12 kv3-1b-potassium-channel-monoclonal-antibody-clone-s16b-8 antibodies ions channels Shaw subfamily subfamilies western blots blotting immunoblotting WB immunohistochemistry IHC oxygen sensors olivocochlear effernet systems proteins potassiums voltage-gated show-related subfamily 0E-12
10011565 L-161,982 147776-06-5 ≥98% 2009-02-26 47.734990791896 l-161-982 PGEs PGE2 EPs EP4 receptors antagonist bone formation inflammation cells proliferation colon cancers L161982 L-161982 47.734990791896
10011562 L-655,240 103253-15-2 ≥98% 2009-10-15 8.148004143646 l-655-240 platelet aggregation smooth muscle constriction contraction antagonist receptors TXA2 receptor TP thromboxane TPα TPβ TXA2 bronchoconstriction L-655240 L 655240 8.148004143646
10009280 L-759,633 174627-50-0 >98% 2007-09-13 33.291215469613 l-759-633 L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic 33.291215469613
10007712 L-902,688 Exclusive 634193-54-7 ≥98% ✓ 2010-05-07 42.970236779794 l-902-688 PGE2 bones growth EP4 agonists hyperalgesia vasodialation 42.970236779794
16812 Latanoprost 130209-82-4 >98% 314.374212154695 latanoprost CAY530500; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α isopropyl ester; 17-phenyl-13,14-dihydro trinor PGF2α isopropyl ester eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors agonists IOP pressure prostaglandins 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. 17-phenyl-13,14-dihydro-trinor-PGF2alpha 314.374212154695
16811 Latanoprost (free acid) 41639-83-2 ≥98% 97.537305972112 latanoprost-free-acid PhXA-85; Lat-FA; 17-phenyl-13,14-dihydro trinor Prostaglandin F2α eyes glaucoma prostaglandins agonists FP receptors phxa85 ophthalmology ophthalmological intraocular acids 17-phenyl-13,14-dihydro-trinor-PGF2.alpha. PhXA85 17-phenyl-13,14-dihydro-trinor-PGF2alpha IOP 97.537305972112
10010329 Lavendustin C 125697-93-0 ≥98% 2008-07-08 11.503353591160 lavendustin-c HDBA; NSC 666251 EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition Lavendustin-C 11.503353591160
20110 Leukotriene B4 71160-24-2 ≥97% 180.943799155021 leukotriene-b4 LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis 180.943799155021
20114 Leukotriene B4-3-aminopropylamide 89596-43-0 ≥95% 2009-03-05 429.324088397790 leukotriene-b4-3-aminopropylamide LTB4-3-aminopropylamide LTB LTB4 BLTs BLT1 BLT2 inflammation immunology 429.324088397790
20115 Leukotriene B4 dimethyl amide 83024-92-4 >97% 90.676325966851 leukotriene-b4-dimethyl-amide LTB4 dimethyl amide leukotrienes LTB4 antagonists analogs BLTR1 receptors amides 90.676325966851
20112 Leukotriene B4 Ethanolamide - >97% 33.184814522494 leukotriene-b4-ethanolamide LTB4-EA BLTR2 receptors leukotrienes LTB4 ethanolamides cannabinoids anandamides ligands BLT2 neuroscience ethanolamines 33.184814522494
20210 Leukotriene C4 72025-60-6 ≥97% 146.582855481245 leukotriene-c4 LTC4 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs 146.582855481245
20310 Leukotriene D4 73836-78-9 >97% 162.167262124002 leukotriene-d4 LTD4 cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes LTD4 asthma SRS-A bronchoconstriction peptido-leukotrienes slow-reacting substance anaphylaxis allergy metabolites 162.167262124002
20410 Leukotriene E4 75715-89-8 >97% 91.881151721207 leukotriene-e4 LTE4 peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes 91.881151721207
10006594 Losartan (potassium salt) 124750-99-8 ≥98% 2005-05-10 40.982331842497 losartan-potassium-salt MK 954; DuP-753 AT1 receptors antagonists angiotensins II type 1 hormones regulates blood pressure regulating hypertension atherosclerosis renal functions vasodilation vasodilating platelets neutrophils aggregation endothelium losartans losartan potassium 40.982331842497
10005280 LPA1 Polyclonal Antibody - 2005-04-05 51.540705954573 lpa1-polyclonal-antibody EDG-2; Vzg-1; LPAR1; LPA Receptor 1 LPA analogs antibodies antisera antiserum western blots blotting wb icc immunocytochemistry GPCRs immunoblotting 51.540705954573
10004840 LPA3 Polyclonal Antibody - 2004-05-11 32.381704814522 lpa3-polyclonal-antibody EDG-7; Lysophosphatidic Acid Receptor 3 analogs antibodies antisera antiserum western blots blotting wb icc immunocytochemistry GPCRs edg7 receptors g-proteins coupled s1p1-5 cellular responses, cytoskeletal rearrangements proliferation inhibits inhibitors inhibition gap junction communication immunoblotting ELISA 32.381704814522
70710 LY171883 88107-10-2 >98% 12.531436464088 ly171883 LTD4 receptors antagonists leukotrienes ly-171883 cysLT1 12.531436464088
10010024 LY223982 Exclusive 117423-74-2 ≥98% ✓ 2008-07-24 2.106629834254 ly223982 SKF 107324; CGS 23131 LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis leukotriene B4 fatty acids 5-LO 5LO CGS23131 SKF107234 2.106629834254
70715 LY255283 117690-79-6 >98% 2004-02-19 38.013121546961 ly255283 receptors antagonists inhibits inhibitors leukotrienes receptors BLT1 BLT2 chemotaxis LY-255283 LY 255283 38.013121546961
10009768 LY293111 Exclusive 161172-51-6 ≥98% ✓ 2009-02-09 62.413743093923 ly293111 Etalocib; VML 295 LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers 62.413743093923
13341 LY364947 396129-53-6 ≥98% 2009-07-23 57.630497237569 ly364947 TGF-β RI Kinase Inhibitor; HTS 466284 TGF-β receptor inhibitors antagonists Smad p38 MAPK MLK-7 cells growth fibroblasts NIH 3T3 cells phosphorylation fibronectin PAI-1 uPA matrigel invasion MDA-MB-231 cells transforming factors LY 364947 LY-364947 HTS-466284 HTS466284 HTS 466284 ALK5 Inhibitor I TβR-I inhibitor Transforming Growth Factor-β Type I Receptor Kinase Inhbitor [3-(Pyridin-2-yl)-4-(4-quinoynyl)]-1H-pyrazole 57.630497237569
600180 Melanocortin-3 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-01-05 16.893913207725 melanocortin-3-receptor-step-reporter-assay-kit-luminescence MC3R MC-3R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH 16.893913207725
10006355 Melanocortin-4 Receptor Polyclonal Antibody - 2005-08-03 12.923232044199 melanocortin-4-receptor-polyclonal-antibody MC4R antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting 12.923232044199
600190 Melanocortin-4 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-01-05 18.301739308369 melanocortin-4-receptor-step-reporter-assay-kit-luminescence MC4R MC-4R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands sexual function antagonists fever suppression inflammatory mediators in vivo Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH 18.301739308369
13820 Misoprostol 59122-46-2 >98% 25.366596685083 misoprostol SC-29333; Cytotec cytoprotection PGE1 analogs agonists EP2 EP3 EP4 receptors SC29333 RU-486 RU486 25.366596685083
70720 MK 571 (sodium salt) - ≥95% 19.976988950276 mk-571-sodium-salt L 660711 LTD4 receptors antagonists leukotrienes mk571 mk-571 salts L660711 L-660711 cysLT1 115104-28-4 19.976988950276
10008318 Montelukast (sodium salt) 151767-02-1 ≥98% 2006-04-20 30.970520915548 montelukast-sodium-salt Singulair® cysteinyl-leukotrienes cysLT1 receptors antagonists LTC4 LTD4 mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries protein-coupled GPCRs selective potent 30.970520915548
10010412 MRE-269 Exclusive 475085-57-5 ≥98% ✓ 2008-11-06 63.403342541436 mre-269 MRE269 prostaglandins PGI2 IP receptors inflammation NS-304 NS304 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs prodrugs 63.403342541436
10230 (+)-Muscarine (iodide salt) 24570-49-8 ≥95% 2010-05-06 0.801602209944 -muscarine-iodide-salt neurochemistry 300-54-9 2438-77-9 poisonous mushroom acetylcholine G proteins Alzheimer's disease signal transduction L-muscarine Amanita muscaria 0.801602209944
13667 Muscimol 2763-96-4 ≥98% 2010-05-28 14.333144396698 muscimol Pantherine; Agarin γ-aminobutyric acid GABA neurotransmitters GABAA GABAC GABAB agonists benzodiazepines memory neurochemistry neuroscience GABA-A Receptor alpha Subunit GABA Benzodiazepine Receptors GABA A Receptor gamma Subunit GABA A Receptor delta Subunit GABA A Receptor alpha Subunit GABA Benzodiazepine Receptor GABA A Receptor beta Subunit Benzodiazepine-GABA Receptor Benzodiazepine GABA Receptor GABA-A Receptor rho Subunit GABA A Receptor rho Subunit Benzodiazepine Receptors Benzodiazepine Receptor Receptors Muscimol Receptors, Diazepam Muscimol Receptor Diazepam Receptor GABA A Receptors GABA-A Receptor GABA A Receptor 14.333144396698
13746 MyD88 Polyclonal Antibody - 2010-02-05 29.845635359116 myd88-polyclonal-antibody proteins antibodies western blots blotting immunoblotting WB interleukin-1 interleukins 1 IL-1 ILs signaling N-terminal NF-κB NFκB NF κB death domain signalling 29.845635359116
13718 Nav1.7 Sodium Channel Monoclonal Antibody (Clone S68-6) - 2009-12-04 0E-12 nav1-7-sodium-channel-monoclonal-antibody-clone-s68-6 antibodies channels ions western blots blotting immunoblotting immunoprecipitation WB IP immunocytochemistry ICC pain sensitivity insensitivity sodiums voltage-gated voltage gated 0E-12
10004184 NESS 0327 Exclusive 494844-07-4 >98% ✓ 2008-05-27 34.593259668508 ness-0327 neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity 34.593259668508
10009818 NF-κB (p50) (human recombinant) - >75% 2007-06-20 24.009060773481 nf-b-p50-human-recombinant NF-κB1; Nuclear Factor-κB (p50) transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b 24.009060773481
10607 NMDA Receptor NR1 Subunit Monoclonal Antibody - 2009-10-26 0.635359116022 nmda-receptor-nr1-subunit-monoclonal-antibody inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate 0.635359116022
10608 NMDA Receptor NR2A Subunit Polyclonal Antibody - 2009-10-26 0.635359116022 nmda-receptor-nr2a-subunit-polyclonal-antibody inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate inhibition immunoprecipitation IP IHC Immunohistochemistry 0.635359116022
10009759 NMDA Receptor NR2B Subunit (Phospho-Tyr1252) Polyclonal Antibody - 2007-02-09 5.314917127072 nmda-receptor-nr2b-subunit-phospho-tyr1252-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting 5.314917127072
10009760 NMDA Receptor NR2B Subunit (Phospho-Tyr1336) Polyclonal Antibody - 2007-02-09 5.314917127072 nmda-receptor-nr2b-subunit-phospho-tyr1336-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting 5.314917127072
10009761 NMDA Receptor NR2B Subunit (Phospho-Tyr1472) Polyclonal Antibody - 2007-02-22 9.230662983425 nmda-receptor-nr2b-subunit-phospho-tyr1472-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor phosphorylation NR2B blotting immunoblotting 9.230662983425
10609 NMDA Receptor NR2B Subunit Polyclonal Antibody - 2009-10-26 0.635359116022 nmda-receptor-nr2b-subunit-polyclonal-antibody N-methyl-D-aspartate Receptor inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors ion channels glutamate IP IHC immunohistochemistry immunoprecipitation 0.635359116022
13390 N-methyl Leukotriene C4 131391-65-6 >97% 2008-10-15 85.482108655616 n-methyl-leukotriene-c4 N-methyl LTC4 allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics 85.482108655616
10115 N-Oleoyl Dopamine 105955-11-1 ≥98% 5.504001578531 n-oleoyl-dopamine ODA VR1 agonists CB1 receptors analogs vanilloids cannabinoids analgesic amides N-oleoyldopamine inhibits inhibitors inhibition 5-lipoxygenases 5-LOs binding selective FAAH hydrolases fatty acid neurochemistry neuroscience cbs synthetic 5.504001578531
10006456 NO-Losartan A 791122-48-0 ≥97% 2005-05-10 41.876298342541 no-losartan-a AT1 receptors antagonists NO-donors nitric oxides angiotensins II type 1 hormones regulates blood pressure regulating hypertension atherosclerosis mammalian renal functions vasodilation vasodilating inhibits platelets neutrophils aggregation endothelium anti-hypertensives losartans 41.876298342541
10007697 N-Palmitoyl Dopamine 136181-87-8 >98% 2005-11-23 5.079447513812 n-palmitoyl-dopamine PALDA N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic 5.079447513812
10010411 NS-304 475086-01-2 ≥98% 2008-04-09 39.075902394106 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 39.075902394106
13641 NVP-AEW541 (hydrochloride) - ≥98% 2010-07-28 41.979834254143 nvp-aew541-hydrochloride 475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 Pyrroles 41.979834254143
10006803 O-1602 317321-41-8 >98% 2005-09-12 11.877928176795 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic 11.877928176795
10006804 O-1821 35482-50-9 >97% 2005-09-12 26.649907918968 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic 26.649907918968
10004914 O-1918 536697-79-7 >98% 2005-09-09 11.646172059984 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic 11.646172059984
10009195 O-2545 (hydrochloride) - ≥98% 2007-07-12 5.521546961326 o-2545-hydrochloride cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic 5.521546961326
10010299 Oleoyl 3-carbacyclic Phosphatidic Acid Exclusive - ≥95% ✓ 2009-10-14 15.632520718232 oleoyl-3-carbacyclic-phosphatidic-acid 3-ccPA 18:1 cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA oleate transcellular migration MM1 cells mesothelial autotoxin cancer survival growth migration invasion metastasis antagonist LPA1 LPA2 LPA3 476310-24-4 15.632520718232
90262 Olvanil 58493-49-5 ≥98% 6.452605893185 olvanil NE 19550; N-Vanillyloleamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs neurochemistry neuroscience 6.452605893185
14070 ONO-8711 216158-34-8 ≥98% 2011-06-15 21.559254143646 ono-8711 ONO 8711 ONO8711 prostaglandins EPs EP1 receptors potent PGs antagonists AH-6809 AH 6809 AH6809 14060 14050 SC-19220 SC19220 SC 19220 21.559254143646
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 10.428937998772 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 10.428937998772
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 9.883163122942 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 9.883163122942
10008642 oxy-Arachidonoyl Ethanolamide - >98% 2007-09-06 13.338195211786 oxy-arachidonoyl-ethanolamide oxy-Anandamide; oxy-AEA oxyanadamide arachidonylethanolamide AEA THC marijuana CB1 CB2 endocannabinoids receptors cannabinoids inhibitors 13.338195211786
360603 PAF Acetylhydrolase Blocking Peptide - 6.615027624309 paf-acetylhydrolase-blocking-peptide PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase western blots blotting controls peptides acetyl hydrolases IHC immunohistochemistry PAF-AH PAFs platlet-activating factors antibodies 6.615027624309
160604 PAF Receptor Blocking Peptide (Polyclonal) - ~30% 10.862265193371 paf-receptor-blocking-peptide-polyclonal Platelet-activating Factor Receptor platelet-activating factors Western blots controls peptides asthma inflammation receptors PAFs antibodies PAFR 10.862265193371
160600 PAF Receptor (human) Monoclonal Antibody (11A4, Clone 21) - 21.703878453038 paf-receptor-human-monoclonal-antibody-11a4-clone-21 Platelet-activating Factor Receptor platelet-activating factors antibodies PAFs ICC immunocytochemistry antisera antiserum flow cytometry FACS receptors atherosclerosis PAFR FC 21.703878453038
160602 PAF Receptor (human) Polyclonal Antibody - 27.475944751381 paf-receptor-human-polyclonal-antibody Platelet-activating Factor Receptor platelet-activating factors antisera PAFs antiserum antibodies flow cytometry facs immunocytochemistry icc western blots blotting wb atherosclerosis PAFR FC immunoblotting 27.475944751381
13032 PD 173074 219580-11-7 ≥98% 2009-07-29 48.426305915947 pd-173074 fibroblast growths factors receptors FGFRs FGFR1 tyrosine kinase activity activities activation signals propagation inhibitors inhibition inhibits autophosphorylation PDGFR c-Src cSrc c Src EGFR InsR MEK PKC FGFR2 FGFR3 FGFR4 FGFR5 angiogenesis cancers tumors self-renewal self renewal stems cells ERK1/2 ERK-1/2 ERK 1/2 48.426305915947
9000849 Phenazepam 51753-57-2 ≥98% 2011-02-14 109.638796807857 phenazepam Fenazepam; BD 98 benzodiazepine agonists GABAA receptors anxiolytic sedative anticonvulsive anti-convulsive anti convulsive hypnotic tranquilizers 109.638796807857
19020 Pinane Thromboxane A2 71111-01-8 >98% 14.260674033149 pinane-thromboxane-a2 PTA2; Pinane TXA2 Thromboxanes analogs TXA2 antagonists TP receptors atherosclerosis 14.260674033149
10525 PK 11195 New 85532-75-8 ≥98% 2012-03-30 130.000000000000 pk-11195 RP 52028 85340-56-3 ligands benzodiazepine neuroscience receptors GABA central peripheral proteins TSPO cerebellum spinal cord tissues RP-52028 RP52028 PK-11195 PK11195 BRN 4264456 130.000000000000
10459 PKC 412 120685-11-2 ≥98% 2010-07-27 25.560131929891 pkc-412 CGP 41251; N-Benzoylstaurosporine; Midostaurin; CGP 41231 inhibitors inhibits inhibition PKC412 PKC-412 serine/threonine serine threonine tyrosines kinases PKCα PKCβ PKCγ PKC-α PKC-β PKC-γ Syk Flk-1 Flk1 Akt PKA c-Kit cKit C-Fgr cFgr FLT3 FLT-3 PDFRβ PDFR-β VEGFR1 VEGF2 nitric oxide synthase eNOS apoptosis cancers angiogenesis signal transduction Staurosporine 25.560131929891
10009088 PPARα LBD (human recombinant) - ≥90% 2006-09-13 56.225207182320 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor α Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting 56.225207182320
61700 PPARγ FL (human recombinant from E. coli) - >90% by SDS-PAGE 2007-01-10 27.604745242480 ppar-fl-human-recombinant-from-e-coli Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone 27.604745242480
10009987 PPARγ FL (human recombinant from Sf21 cells) - ≥80% by SDS-PAGE 2007-06-15 33.559779005524 ppar-fl-human-recombinant-from-sf21-cells Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology 33.559779005524
10007941 PPARγ LBD (human recombinant) - ≥90% 2006-03-16 20.752995702885 ppar-lbd-human-recombinant Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent 20.752995702885
10007451 PPARδ (human recombinant) - ≥95% 2005-07-29 13.889472068754 ppar-human-recombinant NUC1; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 13.889472068754
12010 Prostaglandin D2 41598-07-6 ≥99% 162.543959850903 prostaglandin-d2 PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry 162.543959850903
14010 Prostaglandin E2 363-24-6 ≥99% 254.887908687252 prostaglandin-e2 PGE2; Dinoprostone PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 254.887908687252
16010 Prostaglandin F2α 551-11-1 ≥99% 62.148576378792 prostaglandin-f2 PGF2α; Dinoprost PGF2alpha PGF2.alpha. Lutalyse vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandin f2alpha f2 alpha prostaglandin f2 alpha 62.148576378792
16032 Prostaglandin F2α dimethyl amide 68192-15-4 >98% 9.995876611418 prostaglandin-f2-dimethyl-amide PGF2α dimethyl amide; Dinoprost dimethyl amide PGF2alpha PGF2.alpha. amides prostaglandins FP receptors antagonists 9.995876611418
16033 Prostaglandin F2α dimethyl amine - >98% 16.756368937998 prostaglandin-f2-dimethyl-amine PGF2α dimethyl amine; Dinoprost dimethyl amine PGF2alpha PGF2.alpha. amines prostaglandins FP receptors antagonists 16.756368937998
18220 Prostaglandin I2 (sodium salt) 61849-14-7 ≥99% 83.555215469612 prostaglandin-i2-sodium-salt Prostacyclin; Epoprostenol; PGI2 PGI2 metabolites prostaglandins salts Na+ COX cyclooxygenases atherosclerosis 83.555215469612
18500 Prostaglandin J2 60203-57-8 >95% 43.939123914759 prostaglandin-j2 PGJ2 PGJ2 PGD2 metabolites PPARs prostaglandins peroxisome proliferator-activated receptors 43.939123914759
10008593 PSN375963 388575-52-8 ≥98% 2006-08-01 13.764375690607 psn375963 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology 13.764375690607
10008594 PSN632408 Exclusive 857652-30-3 ≥98% ✓ 2006-08-01 16.772696132596 psn632408 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry 16.772696132596
10009634 Purmorphamine 483367-10-8 ≥98% 2007-07-19 126.553162695672 purmorphamine stem cells differentiation osteoblasts osteogenesis osteoporosis bone smoothened hedgehog progenitor cells expression signalling pathways signaling transmembrane agonists receptors 126.553162695672
10011032 QX-314 (bromide) 24003-58-5 ≥98% 2009-02-03 0.165745856354 qx-314-bromide lidocaine local anesthetic TRPV1 sodium channel blocker pain nociceptor capsaicin 0.165745856354
10006045 (R)-Butaprost (free acid) - >98% 2004-11-09 37.513867403315 -r-butaprost-free-acid 15-deoxy-16R-hydroxy-17-cyclobutyl PGE1; (±)-15-deoxy-16R-hydroxy-17-cyclobutyl PGE1 PGE2 prostaglandins 5,6-dehydro-butaprost free acids EP2 receptors binding selectivity carboxylic acid selective analogs C-16 (R)-epimers 37.513867403315
70600 REV 5901 101910-24-1 >98% 3.833245856353 rev-5901 leukotrienes receptors antagonists lipoxygenases inhibitors inhibits 3.833245856353
10010309 RG-13022 149286-90-8 ≥98% 2008-01-24 1.878891081294 rg-13022 protein tyrosine kinase PTK inhibitors inhibits inhibition antiproliferatives tyrphostin epidermal growth factors EGFs receptors cancers 1.878891081294
10010310 RG-14620 136831-49-7 ≥98% 2008-02-08 1.569600509987 rg-14620 protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative tyrphostin epidermal growth factors EGFs receptors proliferation cancers 1.569600509987
9000484 Rimonabant 168273-06-1 ≥98% 2009-06-17 74.152900552486 rimonabant SR141716 SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic 74.152900552486
10005228 S1P1 Polyclonal Antibody - 2005-02-09 51.358497237568 s1p1-polyclonal-antibody EDG-1; S1PR1; Sphingosine-1-phosphate Receptor 1 antisera antiserum antibodies proteins WB western blots blotting IHC ICC immunohistochemistry immunocytochemistry sphingosine-1-phosphate receptors G-protein-coupled S1P1/EDG-1 S1P2/EDG-5 S1P3/EDG-3 S1P4/EDG-6 S1P5/EDG-8 immunoblotting 51.358497237568
10006373 S1P3 Polyclonal Antibody - 2005-08-23 47.482995702885 s1p3-polyclonal-antibody Sphingosine-1-phosphate Receptor 3; S1PR3; EDG-3 antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry FACS flow cytometry sphingosine-1-phosphates GPCRs G-protein-coupled receptors S1P1 S1P2 S1P4 S1P5 edg-1 edg-5 edg-6 edg-8 couples coupling Gi/o-ERK G12/13-Rho axes mediates cell proliferation survival migration singalling events expressed tissues physiological functions receptors human mouse murine glycosylation N-terminal extracellular domains proteins migrates SDS-PAGE cerbral cortex liver heart immunoblotting 47.482995702885
13489 S1P4 Polyclonal Antibody - 2009-08-25 13.423839779005 s1p4-polyclonal-antibody Sphingosine-1-phosphate Receptor 4; S1PR4; EDG-6 Flow immunoblotting WB western blots immunoblotting ICC immunocytochemistry blotting 13.423839779005
13490 S1P5 Polyclonal Antibody - 2009-08-24 14.551832412522 s1p5-polyclonal-antibody EDG-8; S1PR5; Sphingosine-1-phosphate Receptor 5 Western blots WB immunoblotting S1P immunohistochemistry IHC paraffin blotting EDG-8 EDG8 EDG 8 14.551832412522
10096 SB 242084 (hydrochloride) 1049747-87-6 ≥98% 2010-06-29 1.280536700867 sb-242084-hydrochloride 181632-25-7 serotonins 5-hydroxytryptamines 5-HT neurotransmitters neuroscience receptors gut central nervous system antagonists 5-HT2C dopamine adrenergic receptors brain anxiolytic neurochemistry CNS Antigens HLA-SB Antigens HLA-PL Antigens HLA-DP HLA-SB Antigens HLA-PL Antigens HLA-DP Antigens HLA SB Antigens HLA PL Antigens HLA DP Antigens HLA-SB HLA-PL HLA-DP 1.280536700867
11019 SB 366791 472981-92-3 ≥98% 2011-10-13 9.380497237569 sb-366791 pain TRPV1 antagonists hyperalgesia receptors neurons central peripheral nerves terminals thermal mechanical hyperalgesia bone cancers ganglion SB366791 SB-366791 9.380497237569
13031 SB 431542 301836-41-9 ≥98% 2009-08-10 104.892580110497 sb-431542 inhibitors inhibits inhibitions TGF-β1 TGFβ1 receptors ALK5 ALK4 ALK7 ALKs BMP ALK2 ALK3 ALK6 kinases Smad fibrosis cancers renewal embryonic stems cells induced pluripotent differentiation SB431542 104.892580110497
14060 SC-19220 19395-87-0 >96% 61.538110497237 sc-19220 PGE2 antagonists antinociceptives EP1 receptors selective prostaglandins SC19220 SC 19220 61.538110497237
10011561 SC-51089 146033-02-5 ≥95% 2010-02-02 10.908080110497 sc-51089 CID132748 prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs Oxazepines 10.908080110497
10010744 SC-51322 146032-79-3 >98% 2010-03-09 17.113646408840 sc-51322 SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol (11alpha.13E,16S)-Isomer Misoprostol (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Misoprostol (11alpha,13E)-Isomer Grunenthal Brand of Misoprostol Novopharm Brand of Misoprostol Misoprostol Grunenthal Brand Pfizer Brand of Misoprostol Misoprostol Novopharm Brand Apotex Brand of Misoprostol Misoprostol Pfizer Brand Misoprostol Apotex Brand Novo-Misoprostol Novo Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol SC-30249 SC-29333 SC 30249 SC 29333 SC30249 SC29333 Cytotec Glefos 17.113646408840
10006440 SEW2871 256414-75-2 >98% 2005-03-09 81.383655616943 sew2871 FTY720 sphingosines 1-phosphates receptor-1 S1P1 agonists immunosuppression brandycardia G-proteins receptors lymphocytes recirculation blood heart rate GPR FTY 720 sew 2871 81.383655616943
10009312 SKF-96365 (hydrochloride) 130495-35-1 ≥98% 2007-01-19 47.533237569061 skf-96365-hydrochloride calcium antagonists voltage-gated inhibits inhibitors inhibition acetylcholine-induced depolarization smooth muscles platelets neutrophils SFK9635 Ach-induced HCl neurochemistry 47.533237569061
62570 Sphingosine-1-Phosphate 26993-30-6 ≥98% 130.741114497999 sphingosine-1-phosphate S1P; Sphingosine-1-Phosphoric Acid sphingosines phosphates ceramides apoptosis Sphingosine-1-phosphoric acids cells death kinases sphingomyelin growth calcium 130.741114497999
19025 SQ 29,548 98672-91-4 ≥98% 95.835127071823 sq-29-548 thromboxanes TXA2 SQ-29548 SQ29548 analogs TP antagonists receptors atherosclerosis 95.835127071823
10009022 (S)-SLV 319 Exclusive 464213-10-3 ≥98% ✓ 2007-08-16 0.254419889503 -s-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands 0.254419889503
14765 Sulprostone 60325-46-4 >98% 184.736961325967 sulprostone 16-phenoxy-PGE2 EP3 agonists selective analogs receptors 184.736961325967
10005440 Tafluprost 209860-87-7 >98% 2004-10-05 112.540037390479 tafluprost AFP-168 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular acids 17-phenyl trinor-PGF2.alpha. 17-phenyl trinor-PGF2alpha 15-deoxy-15,15-difluoro PGF analogs 16-phenoxy hypotensive 112.540037390479
10005439 Tafluprost (free acid) 209860-88-8 >98% 2004-09-22 87.907304218188 tafluprost-free-acid AFP-172 eyes glaucoma prostaglandins agonists FP receptors ophthalmology ophthalmological intraocular AFP172 hypotensives pressure IOP 87.907304218188
13258 Tamoxifen 10540-29-1 ≥98% 2010-01-21 75.908419802325 tamoxifen nuclear receptors 17β-estradiol estrogen ERα ERβ modulators antagonists breast cancers tumors agonists bones osteoporosis cardiovascular disease menopause women uterus uterine endometrial carcinomas Nolvadex Istubal Valodex Savient brand of Tamoxifen Citrate Citrate Tamoxifen Tamoxifen Citrate Zitazonium Tomaxithen ICI-4 474 ICI 46 474Tamoxifen ICI-47699 ICI-46474 ICI46474ICI 47699 ICI 46474 Soltamox Novaldex Nolvadex ICI47699 ICI46474 75.908419802325
10011348 Taprostene (free acid) Exclusive 108945-35-3 ≥95% ✓ 2009-11-11 43.647412523020 taprostene-free-acid CG 4203; Rheocyclan prostacyclins PGI2 receptors IP IP1 EP4 vascular smooth muscles relaxation analogs potential antagonists tissues preparations CG-4203 CG4203 SE63 SE-63 SE 63 43.647412523020
10007565 Tetradecyl Phosphonate 4671-75-4 >98% 2005-10-17 49.791160220994 tetradecyl-phosphonate pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter 49.791160220994
10011127 Thioperamide Maleate 148440-81-7 ≥98% 2009-03-26 0.202209944751 thioperamide-maleate histamines H3 receptors antagonists seizures GABA 110-16-7 106243-16-7 selective croses blood-brain barrier 0.202209944751
19030 Thromboxane B2 54397-85-2 ≥99% 103.580638428483 thromboxane-b2 TXB2 thromboxanes platelets metabolites TXB2 intrarenal TXA2 urine urinary atherosclerosis 103.580638428483
11111 Toll-Like Receptor 10 Monoclonal Antibody (Clone 3C10C5) - 2011-11-18 0.572551481667 toll-like-receptor-10-monoclonal-antibody-clone-3c10c5 TLR10; CD290 TLRs innate immune systems transmembrane proteins cells patterns recognition receptors PRRs pathogen-associated molecular PAMPs signaling TIR domains Flow cytometry FC TLR10 TLR-10 0.572551481667
13585 Toll-Like Receptor 11 Polyclonal Antibody - 2009-11-12 0.484466638334 toll-like-receptor-11-polyclonal-antibody TLR11 antibodies toll like TLRs western blotting blots immunoblotting WB intracellular flow cytometry FC bacterias kidneys interinal organs 0.484466638334
13586 Toll-Like Receptor 12 Polyclonal Antibody - 2009-11-23 0.484466638334 toll-like-receptor-12-polyclonal-antibody TLR12 antibodies toll like TLRs western blots blotting immunoblotting WB FC flow cytometry macrophages liver kidney bladder epithelial cells intracellular 0.484466638334
13582 Toll-Like Receptor 1 Polyclonal Antibody - 2009-10-10 1.500361240969 toll-like-receptor-1-polyclonal-antibody TLR1 antibodies toll like TLRs receptor-1 receptors mammals transmembrane proteins leucine WB western blots blotting immunoblotting flow intracellular cells surface TLR2 lipids lipoproteins 1.500361240969
13587 Toll-Like Receptor 2 Monoclonal Antibody (Clone TL2.1) - 2009-11-01 3.187399065023 toll-like-receptor-2-monoclonal-antibody-clone-tl2-1 TLR2 antibodies TL21 toll like CHO cells TLRs mammals flow cytometry FC immunoflurescence IF immunocytochemistry ICC immunoprecopitation IP immunohistochemisty IHC western blots immunoblotting blotting WB receptors TLRs 3.187399065023
13588 Toll-Like Receptor 3 Monoclonal Antibody (Clone 40C1285.6) - 2009-10-27 0.484466638334 toll-like-receptor-3-monoclonal-antibody-clone-40c1285-6 TLR3 toll like TLRs receptors western blot WB blotting immunoblotting flow cytometry FC intracellular cell surface immunoprecipitation IP immunohistochemisty IHC immunocytochemistry ICC immunofluorescence IF interleukin-1 IL-1 antibodies 0.484466638334
13589 Toll-Like Receptor 4 Monoclonal Antibody (Clone HTA125) - 2009-10-27 0.484466638334 toll-like-receptor-4-monoclonal-antibody-clone-hta125 TLR4 antibodies toll like receptors flow cytometry FC intracellular cell surface immunoprecipitation IP FA neutralization immunofluorescence immunocytochemistry IF ICC confocal microscopy TLRs immunoblotting blotting 0.484466638334
13595 Toll-Like Receptor 5 Monoclonal Antibody (Clone 85B152.5) - 2009-10-27 0.484466638334 toll-like-receptor-5-monoclonal-antibody-clone-85b152-5 TLR5 antibodies WB FC intracellular cells surface TLRs western blotting blots immunoblotting flow cytometry 0.484466638334
13591 Toll-Like Receptor 7 Polyclonal Antibody - 2009-11-23 0.484466638334 toll-like-receptor-7-polyclonal-antibody TLR7 receptors tolls like antibodies TLRs western blots blotting immunoblotting WB flow cytometry FC intracellular cells surface immunohistochemistry IHC frozen paraffin-embedded sections paraffin embedded immunocytochemistry ICC immunoprecipitation IP TLR7 TLR 7 0.484466638334
13592 Toll-Like Receptor 8 Monoclonal Antibody (Clone 44C143) - 2009-11-09 0.484466638334 toll-like-receptor-8-monoclonal-antibody-clone-44c143 TLR8 antibodies blotting immunoblotting WB western blots IHC immunohistochemistry flow cytometry FC intracellular cells surface paraffin embedded sections paraffin-embedded exons cDNATLRs TLR-8 TLR 8 0.484466638334
13593 Toll-Like Receptor 9 Monoclonal Antibody (Clone 26C593.2) - 2009-11-09 2.579239269018 toll-like-receptor-9-monoclonal-antibody-clone-26c593-2 TLR9 antibodies western blots blotting immunoblotting tolls like bacterial DNA confocal microscopy flow cytometry FC intracellular cell surface immunohistochemistry IHC frozen paraffin-embedded sections paraffin embedded immunofluorscence IF immunocytometry ICC 2.579239269018
10004452 TP Receptor (human) Polyclonal Antibody - 2004-04-01 107.429983425413 tp-receptor-human-polyclonal-antibody TXA2 Receptor; Thromboxane A2 Receptor thromboxanes platelets metabolites TXA2 IHC immunohistochemistry antibodies antisera antiserum western blot blotting WB atherosclerosis immunoblotting ICC immunocytochemistry 107.429983425413
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 56.391240024554 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 56.391240024554
101882 TP Receptor (mouse) Polyclonal Antibody - 80.362312549329 tp-receptor-mouse-polyclonal-antibody Thromboxane A2 Receptor; TXA2 Receptor thromboxanes platelets metabolites TXA2 IHC immunohistochemistry antibodies antisera antiserum western blots blotting immunoblotting WB 80.362312549329
60950 (±)trans-2,5-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane 116673-45-1 ≥98% 4.326817679558 -trans-2-5-bis-3-4-5-trimethoxyphenyl-1-3-dioxolane trans-BTP Dioxolane PAFs antagonists dioxolanes receptors platelet-activating factors (±)trans-2,4-bis-(3,4,5-Trimethoxyphenyl)-1,3-dioxolane 4.326817679558
10162 Treprostinil 81846-19-7 >98% 2005-08-30 75.237668508287 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 75.237668508287
13719 TRPC4 Calcium Channel Monoclonal Antibody (Clone S77-15) - 2009-12-04 0E-12 trpc4-calcium-channel-monoclonal-antibody-clone-s77-15 Transient Receptor Potential Cation Channel antibodies western blots blotting immunoblotting WB ICC immunocytochemistry IP immunoprecipitation proteins smooth muscle endothelial cells nerves injuries injury c coupled c-coupled receptors 0E-12
13720 TRPM7 Ion Channel Ser/Thr Kinase Monoclonal Antibody (Clone S74-25) - 2009-12-04 0E-12 trpm7-ion-channel-ser-thr-kinase-monoclonal-antibody-clone-s74-25 antibodies WB western blots blotting immunoblotting immunoprecipitation IP immunocytochemistry ICC TRPs proteins channels ions ATPs calcium transient receptors potential 0E-12
13721 TRPV3 Channel Monoclonal Antibody (Clone S15-4) - 2009-12-04 0E-12 trpv3-channel-monoclonal-antibody-clone-s15-4 Transient Receptor Potential Cation Channel antibodies WB western blots blotting immunoblotting ICC immunocytochemistry immunoprecipitation IP channels ions chromosome 17 temperature sensation vasoregulation 0E-12
16440 U-44069 56985-32-1 >98% 235.746519337017 u-44069 9,11-dideoxy-9α,11α-epoxymethano Prostaglandin F2α; 9,11-dideoxy-9α,11α-epoxymethano PGF2α; 9,11-epoxymethano Prostaglandin H2 endoperoxides methanoepoxy PGH2 thromboxanes analogs prostaglandins U44069 TP receptors agonists atherosclerosis 235.746519337017
16450 U-46619 56985-40-1 >98% 225.073822199899 u-46619 9,11-dideoxy-9α,11α-methanoepoxy Prostaglandin F2α; 9,11-dideoxy-9α,11α-methanoepoxy PGF2α endoperoxides PGH2 thromboxanes vasoconstriction analogs TP receptors agonists U46619 atherosclerosis 225.073822199899
10010522 U-46619 Glycine methyl ester - >98% 2008-03-24 110.487127071823 u-46619-glycine-methyl-ester TP receptors agonists inflammations PGH2 endoperoxides thromboxanes vasoconstriction analogs U46619 3 prodrugs forms 110.487127071823
70705 U-75302 119477-85-9 >98% 23.604364640884 u-75302 LTB4 receptors antagonists leukotrienes u75302 23.604364640884
13261 URB447 Exclusive 1132922-57-6 ≥98% ✓ 2009-06-18 35.040220994475 urb447 CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic 35.040220994475
10007452 Vinclozolin M2 83792-61-4 >98% 2005-10-19 72.987440147329 vinclozolin-m2 M2 M1 antiandrogen androgens receptors fungicides antagonists rats dicarboximides controls diseases Botrytis cineera Sclerotinia sclerotiorum Monilinia grapes fruitss vegetables ornamentals plants turfgrass metabolites fathead minnows high-affinity low capacity testosterones binding sites brain ovary cytosolic functions endocrinology 72.987440147329
10010992 W123 Exclusive - ≥98% ✓ 2008-11-14 61.497002762431 w123 FTY720 sphingosines sphingosine-1-phosphate receptors S1P S1P1 EDG1 EDG-1 inhibitors inhibits inhibition SEW2871 FTY 720 antagonist 61.497002762431
10009109 W146 (trifluoroacetate salt) - ≥95% 2010-03-10 75.952498465316 w146-trifluoroacetate-salt S1Ps sphingosine-1-phosphates sphingosines phosphates lymphocytes S1P1 antagonists immunity capillary leakage antagonists GPCR G protein-coupled receptors S1P2 S1P3 S1P5 TFA salts Phosphonic Acid Esters Phosphonic Acids Phosphonates 75.952498465316
13246 YM-58483 223499-30-7 ≥98% 2009-11-16 5.369171270719 ym-58483 BTP 2 calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT 5.369171270719
10008282 Zafirlukast 107753-78-6 ≥97% 2006-05-01 18.503117600631 zafirlukast Accolate® cysteinyl-leukotrienes cysLT1 receptors GPCRs protein-coupled antagonists asthma asthmatic allergies allergic rhinitis selective cysLTs cys-LTs cys-LT1 accolate™ 18.503117600631
18550 Δ12-Prostaglandin J2 87893-54-7 ≥95% 62.919779005524 -12-prostaglandin-j2 Δ12-PGJ2 delta12-PGJ2 d12-PGJ2 .DELTA.12-PGJ2 antitumor antimitotic PPARgamma PPAR.gamma. PPARs peroxisome proliferator-activated receptors prostaglandins ligands 62.919779005524
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?